Largest clinical dataset of its kind driving diagnosis and discovery worldwide GAITHERSBURG, MD, Sept. 21, 2021 – GeneDx, Inc., a leader in genomic analysis, a wholly owned subsidiary of BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced it has completed clinical genetic exome sequencing for more than 300,000 patients, making the company’s dataset […]
Tag Archives: genedx
ALCA Blog and Video Delivering answers for patients isn’t just a job, it’s a calling. For Katie Aoyama, the Assistant Director of the Technology, Transfer and Validation Department at GeneDx, a subsidiary of BioReference Laboratories, Inc. and OPKO Health Company, each day offers an opportunity to rethink what it means to put patients first and […]
Press Release
OPKO Health’s GeneDx Adds Repeat Expansion Analysis Genetic Tests for Diagnosis of Spinocerebellar Ataxia (SCA), Friedreich Ataxia, and Other Common Forms of Hereditary Ataxia
26
Jan
Jan
GAITHERSBURG, Md., January 26, 2021 — GeneDx, Inc., a wholly owned subsidiary of BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today launched several new genetic tests, including repeat expansion analysis for spinocerebellar ataxia (SCA), Friedreich ataxia, and other common forms of hereditary ataxias. With these additions, GeneDx has created a comprehensive and affordable offering that covers the […]
News
OPKO Health’s GeneDx Enters into Agreement with Pediatrix Medical Group to Offer Neonatal Genomic Services
12
Aug
Aug
GAITHERSBURG, Md., August 12, 2020 – GeneDx, Inc., a subsidiary of BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), the global leader in neonatal and pediatric genetic testing, announced the entrance into an agreement with Pediatrix Medical Group (“Pediatrix”), the nation’s leading provider of maternal-fetal, and pediatric medical and surgical subspecialty physician services, to offer state-of-the-art, […]
Press Release
OPKO Health’s GeneDx Adds GenomeXpress to Its Industry-Leading Clinical Genomics Portfolio
06
Aug
Aug
GenomeXpress is a rapid genome sequencing test, reporting results within approximately seven days GAITHERSBURG, Md., Aug. 6, 2020 /PRNewswire/ — GeneDx, Inc., a subsidiary of BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced the launch of GenomeXpress, a rapid genome sequencing test. Verbal GenomeXpress results of pathogenic and/or likely pathogenic variants in known disease causing genes are […]
Press Release
OPKO Health’s BioReference Laboratories and GeneDx Increase COVID-19 Response Through Expanded Testing Capacity
20
Apr
Apr
GeneDx’s Gaithersburg and BioReference’s Melbourne facilities offer COVID-19 testing ELMWOOD PARK, N.J., April 20, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced its subsidiary GeneDx will begin testing for COVID-19 to further expand public access to testing. In addition, BioReference will leverage its Melbourne, Florida facility to increase COVID-19 testing capacity, […]
06
Mar
Mar
We’re celebrating something BIG today – our specialty genetics laboratory, GeneDx, turns 20! If you haven’t heard of GeneDx, they are a global leader and pioneer in advanced genetic and genomics testing, and specialize in diagnosing rare and ultra-rare disorders. With over 300 million people in the world living with a rare disease, GeneDx’s 20 […]
Press Release
BioReference Laboratories and GeneDx to Present at NSGC 2019, Demonstrating Commitment to Genetic Counselors and the Research of Rare Genetic Disorders
04
Nov
Nov
Elmwood Park, NJ, Nov. 04, 2019 (GLOBE NEWSWIRE) — BioReference Laboratories, Inc., an OPKO Health Company, along with its genetics and genomics laboratory, GeneDx, and women’s health division, GenPath, today announced the presentation of new research from its genetics program at the National Society for Genetic Counselors (NSGC) 38th Annual Conference in Salt Lake City, […]